Comparison of Effectiveness of Programmed Death Protein 1 and Programmed Death Ligand 1 Inhibitors in Extensive-Stage Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Effectiveness of Programmed Death Protein 1 and Programmed Death Ligand 1 Inhibitors in Extensive-Stage Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials and Observational Studies

Published:2024-03-06 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Damarpally Nanush,Arrey Agbor Divine Besong,Sinha Tanya,Gugulothu Kalyan Naik,Myint Ye Kyaw,Chaudhari Sandipkumar S,Allahwala Danish

Publisher

Springer Science and Business Media LLC

Reference24 articles.

1. Immunotherapeutic approaches for small-cell lung cancer;Iams WT;Nat Rev Clin Oncol,2020

2. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages;Wang S;Sci Rep,2017

3. A systematic review of survival following anti-cancer treatment for small cell lung cancer;Jones GS;Lung Cancer,2020

4. Small cell lung cancer (SCLC): no treatment advances in recent years;Koinis F;Transl Lung Cancer Res,2016

5. Pembrolizumab in patients with extensive-stage small-cell lung cancer: results from the phase Ib KEYNOTE-028 study;Ott PA;J Clin Oncol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP